Global Diagnostic Imaging Systems Market Report 2020: Industry Dynamics and Competitive Benchmarking to 2030

March 15, 2021

Global Diagnostic Imaging Systems Market Report: Generated $38.9 billion in 2019 and will increase to $70.0 billion in 2030.

Factors such as the escalating healthcare expenditure, burgeoning number of diagnostic imaging centers, growing requirement for diagnostic imaging procedures, booming population of the elderly, continuous technological developments in diagnostic imaging, and rising prevalence of chronic diseases are expected to drive the diagnostic imaging systems market at a CAGR of 5.8% during the forecast period (2020-2030).

One of the leading factors supporting the diagnostic imaging systems market growth is the surge in the geriatric population. According to the World Population Ageing report of 2019 of the United Nations (UN), the population of people aged 65 years and above is expected to reach nearly 1.5 billion in 2050. Older people need extensive care, as they are more susceptible to chronic diseases due to their weak immunity levels. Due to this, the demand for diagnostic imaging systems will continue to escalate during the forecast period.

Currently, the diagnostic imaging systems market is witnessing the trend of product launches. The new high-quality imaging systems are facilitating access to advanced diagnosis with fast and accurate results. For instance, Carestream Health Inc. launched the DRX-Compass X-ray System in August 2020 to provide a scalable and flexible approach to digital imaging. The system, marketed to diagnostic imaging centers and hospitals, assists in vertical auto-centering and auto-tracking. Similarly, in July 2020, Hologic Inc. launched a cart-based system ultrasound system, named SuperSonic MACH 40, in the U.S. to offer a high image quality and various imaging modes.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 X-ray imaging systems

4.1.1.1.1 By technology

4.1.1.1.1.1 Digital

4.1.1.1.1.2 Analog

4.1.1.1.2 By portability

4.1.1.1.2.1 Stationary

4.1.1.1.2.2 Portable

4.1.1.2 MRI systems

4.1.1.2.1 By type

4.1.1.2.1.1 Closed

4.1.1.2.1.2 Open

4.1.1.2.2 By field strength

4.1.1.2.2.1 Mid

4.1.1.2.2.2 High

4.1.1.2.2.3 Low

4.1.1.3 Ultrasound systems

4.1.1.3.1 By technology

4.1.1.3.1.1 3D and 4D

4.1.1.3.1.2 2D

4.1.1.3.1.3 Doppler imaging

4.1.1.3.2 By portability

4.1.1.3.2.1 Trolley/cart-based

4.1.1.3.2.2 Compact/portable

4.1.1.4 CT scanners

4.2.2.1.1 By slice

4.1.1.5 Nuclear imaging systems

4.1.1.6 Others

4.1.2 By Application

4.1.2.1 Cardiology

4.1.2.2 Oncology

4.1.2.3 Neurology

4.1.2.4 Orthopedics

4.1.2.5 Urology

4.1.2.6 Dentistry

4.1.2.7 Ophthalmology

4.1.2.8 OB/GYN

4.1.2.9 Others

4.1.3 By End User

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing number of product launches

4.2.1.2 Rising number of collaborations and acquisitions

4.2.2 Drivers

4.2.2.1 Increasing number of healthcare settings

4.2.2.2 Increasing healthcare expenditure

4.2.2.3 Growing need for diagnostic imaging procedures

4.2.2.4 Surge in the prevalence of chronic diseases

4.2.2.5 Technological advancements in diagnostic imaging

4.2.2.6 Surging geriatric population

4.2.2.7 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of development and maintenance of diagnostic imaging systems

4.2.3.2 Stringent regulations

4.2.3.3 Diminishing helium reserves

4.2.3.4 Increasing risk of cancer due to exposure to radiation

4.2.3.5 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.4 Impact of COVID-19

4.5 Regulatory Scenario for Diagnostic Imaging Systems

4.6 Pricing Analysis

4.7 Maintenance Cost Associated with Diagnostic Imaging Systems

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 X-Ray Imaging Systems Market

5.1.1.1 By technology

5.1.1.2 By portability

5.1.2 MRI Systems Market

5.1.2.1 By type

5.1.2.2 By field strength

5.1.3 Ultrasound Systems Market

5.1.3.1 By technology

5.1.3.2 By portability

5.1.4 CT Scanners Market

5.1.4.1 By slice

5.2 By Application

5.3 By End User

5.4 By Region

Chapter 6. North America Market Size and Forecast

Chapter 7. Europe Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Competitive Landscape

11.1 Market Share Analysis of Key Players

11.2 Competitive Benchmarking

11.3 Strategic Developments of Key Players

11.3.1 Product Launches and Approvals

11.3.2 Acquisitions

11.3.3 Partnerships

11.3.4 Other Developments

Chapter 12. Company Profiles

  • General Electric Company
  • Siemens AG
  • Koninklijke Philips N.V.
  • Dragerwerk AG & Co. KGaA
  • FUJIFILM Holdings Corporation
  • Hitachi Ltd.
  • Agfa-Gevaert N.V.
  • Canon Inc.
  • Carestream Health Inc.
  • Shimadzu Corporation
  • Esaote S.p.A.
  • Mindray Bio-Medical Electronics Co. Ltd.
  • Analogic Corporation
  • Samsung Electronics Co. Ltd.
  • Hologic Inc.
  • Konica Minolta Inc.
  • KARL STORZ SE & Co. KG
  • DEL MEDICAL Inc.
  • Dornier MedTech GmbH
  • Varex Imaging Corporation
  • Bruker Corporation
  • Fonar Corporation
  • Neusoft Corporation
  • Aurora Healthcare US Corp
  • Time Medical Holding
  • Aspect Imaging Ltd.
  • SonoScape Medical Corporation
  • SternMed GmbH

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”